CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class: Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
Symbol: CRMD on Nasdaq
Shares outstanding: 79,310,345
Price per share: $8.02
All holders as of 31 Dec 2025: Q4 2025
Total 13F shares: 41,704,039
Total reported value: $484,924,879
% of total 13F portfolios: 0%
Share change: -1,533,662
Value change: -$17,969,861
Number of holders: 197
Price from insider filings: $8.02

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Deep Track Capital, LP	6.3%		$55,204,125		4,955,487		Deep Track Capital, LP	21 Nov 2025
SHAIBATALHAMD AYMEN ABDALKADER	5.8%	-6.7%	$44,390,000	-$440,330	4,600,000	-0.98%	SHAIBATALHAMD AYMEN ABDALKADER	01 Jan 2026
BlackRock, Inc.	7.5%		$41,659,221		4,567,897		BlackRock, Inc.	31 Dec 2024

As of 31 Dec 2025, 197 institutional investors reported holding 41,704,039 shares of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD). This represents 53% of the company’s total 79,310,345 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) together control 40% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution	Ownership %	Shares Held	Share Change %	Portfolio %	Holdings Value
BlackRock, Inc.	7.3%	5,776,428	+1.5%	0%	$67,179,857
Deep Track Capital, LP	6.6%	5,274,076	+955%	1.4%	$61,337,504
VANGUARD GROUP INC	5.7%	4,499,010	+13%	0%	$52,323,486
MARSHALL WACE, LLP	2.5%	1,966,262	-43%	0.02%	$22,867,628
STATE STREET CORP	2.4%	1,920,861	+4.6%	0%	$22,339,613
GEODE CAPITAL MANAGEMENT, LLC	2.4%	1,912,233	+5.7%	0%	$22,242,743
DEERFIELD MANAGEMENT COMPANY, L.P.	1.4%	1,107,944	-67%	0.17%	$12,885,389
Alyeska Investment Group, L.P.	1.1%	850,000	-33%	0.03%	$9,885,500
GOLDMAN SACHS GROUP INC	1%	828,781	+259%	0%	$9,638,723
OBERWEIS ASSET MANAGEMENT INC/	1%	805,115	+2.5%	0.34%	$9,363,487
KENNEDY CAPITAL MANAGEMENT LLC	0.83%	658,105	-0.08%	0.16%	$7,653,761
MORGAN STANLEY	0.82%	648,762	-23%	0%	$7,545,108
UBS Group AG	0.8%	636,035	-42%	0%	$7,397,088
NORTHERN TRUST CORP	0.77%	614,598	-0.16%	0%	$7,147,775
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	0.77%	610,928	+4.5%	0%	$7,105,093
Palisades Investment Partners, LLC	0.73%	576,759	+2.2%	2.5%	$6,707,707
RAYMOND JAMES FINANCIAL INC	0.59%	465,441	-29%	0%	$5,413,078
Squarepoint Ops LLC	0.54%	432,215	+129%	0.01%	$5,026,660
Private Advisor Group, LLC	0.48%	378,537	+39%	0.02%	$4,402,391
Bank of New York Mellon Corp	0.48%	376,907	+46%	0%	$4,383,429
NEW YORK STATE COMMON RETIREMENT FUND	0.4%	320,997	+7.9%	0%	$3,733,195
CITADEL ADVISORS LLC	0.4%	320,150	-81%	0%	$3,723,344
VICTORY CAPITAL MANAGEMENT INC	0.4%	314,970	+34%	0%	$3,663,101
October Effect Ltd	0.39%	306,444	-27%	3.9%	$3,563,944
Assenagon Asset Management S.A.	0.38%	302,508	+35%	0.01%	$3,518,168

Institutional Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	41,704,039	$484,924,879	-$17,969,861	$16,015,673	$24,049,677	$11.63	197
2025 Q3	43,121,910	$501,528,237	+$101,799,375	$15,143,423	$15,473,715	$11.63	189
2025 Q2	34,151,234	$420,699,898	+$142,837,808	$6,911,398	$10,694,248	$12.32	169
2025 Q1	23,724,937	$146,235,596	+$397,499	$4,815,472	$2,981,882	$6.16	135
2024 Q4	22,893,836	$185,441,545	+$29,955,443	$3,244,050	$4,853,520	$8.10	126
2024 Q3	19,135,638	$154,655,147	+$21,831,393	$3,565,263	$1,081,776	$8.08	100
2024 Q2	17,129,390	$74,162,669	-$748,246	$1,551,439	$305,265	$4.33	97
2024 Q1	17,269,642	$73,216,929	-$5,693,027	$1,240,624	$393,896	$4.24	89
2023 Q4	18,742,007	$70,461,032	+$3,045,526	$1,071,600	$394,048	$3.76	101
2023 Q3	17,891,223	$66,197,207	-$5,485,628	$1,498,500	$294,520	$3.70	92
2023 Q2	19,187,043	$76,065,204	+$33,053,416	$1,106,789	$434,785	$3.96	86
2023 Q1	10,770,110	$44,582,136	-$1,863,278	$1,020,480	$669,536	$4.14	64
2022 Q4	11,182,776	$47,050,210	+$1,816,100	$1,240,262	$280,926	$4.22	62
2022 Q3	10,928,271	$31,131,890	-$4,497,215	$417,000	$230,000	$2.83	66
2022 Q2	12,425,504	$49,348,797	-$5,601,808	$440,000	$220,000	$4.02	69
2022 Q1	13,362,668	$73,354,516	+$1,886,576	$618,000	$458,000	$5.48	83
2021 Q4	13,046,114	$59,435,463	+$5,549,733	$299,000	$315,000	$4.55	78
2021 Q3	11,793,247	$54,910,109	+$1,590,384	$377,000	$534,000	$4.65	75
2021 Q2	11,351,356	$77,873,368	+$3,221,689	$926,000	$1,683,000	$6.86	77
2021 Q1	10,781,064	$107,630,096	+$16,345,897	$1,737,000	$3,224,000	$9.99	76
2020 Q4	9,261,298	$68,791,909	+$7,239,796	$1,162,000	$593,000	$7.43	74
2020 Q3	8,327,514	$50,205,664	+$9,581,252	$583,000	$433,000	$6.03	70
2020 Q2	6,739,459	$42,456,689	+$1,328,313	$781,000	$252,000	$6.30	67
2020 Q1	6,612,416	$23,732,293	-$6,155,816	$457,000	$47,000	$3.59	57
2019 Q4	6,440,146	$46,873,565	+$176,523	$793,000	$104,000	$7.28	62
2019 Q3	6,472,987	$41,291,108	+$6,489,686	$497,000	$163,000	$6.38	55
2019 Q2	5,421,031	$48,610,180	+$15,505,635	$1,010,000	$1,581,000	$8.97	45
2019 Q1	3,663,429	$34,616,000	+$34,616,000	$1,543,000	$1,747,000	$9.45	37